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Résumé en
anglais
Delivery of therapeutic agents into the brain has been an ongoing challenge for many
years. The poor prognosis for patient with primary malignant brain tumors treated
with conventional techniques (surgery, radiotherapy and chemotherapy) has
motivated the development of new strategies to deliver drugs into the brain. Local
intracranial delivery of antineoplastic agents has appeared to be the most effective
drug delivery technique into the central nervous system by circumventing the
limitations imposed by the blood brain barrier (BBB). Convection-enhanced delivery
(CED) is an alternative strategy to directly infuse drugs into brain tissue. This
approach is based on continuous injection of the therapeutic agent under
positive pressure via a catheter implanted into the brain. Convective transport driven
by pressure gradient allows a widespread distribution of small and large drugs within
the brain. In vivo experiments in rodents, cats and primates proved the efficacy of
CED to deliver drugs into a targeted zone. However, clinical trials have reported
frequent leakage phenomenon leading to mixed results for this delivery technique. A
better optimization of operational parameters including infusion rate, catheter
design, catheter placement and drug pharmacological formulation should allow
achieving accurate and efficient delivery. In conjunction with CED, the use of
nanocarriers to enhance drug pharmacokinetic behavior may help to achieve higher
therapeutic index against tumor cells over healthy tissues. Additionally, the
development of computer simulation to predict drug distribution and the real-time
imaging for immediate assessment of convection efficiency may contribute to the
CED improvement.
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